Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin in pediatric intravascular procedures
NCT00503126Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of bivalirudin in congenital heart disease (CHD), sponsored by The Medicines Company. Started Aug 2007; status: completed.
02
Drugs
bivalirudin
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT00503126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503126.